Evidence map›Paper›PMID 39981939›Full record

ArticleAnnals of neurology2025

Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study.

Nunu Laura Timotheussen Lund, Connar Stanley James Westgate, Marie-Louise Kulas Søborg, Agneta Henriette Snoer, Rigmor Højland Jensen, Thomas Folkman Hansen, Anja Sofie Petersen

Abstract read
In one paragraph

Article in Annals of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Adrenal gland dysfunction in males with cluster headache.The journal of headache and pain · 2026
    Article
  4. MRGPRX2 as a novel therapeutic target in headache.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nunu Laura Timotheussen LundDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.ORCID 0000-0003-3062-030X
Connar Stanley James WestgateDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.ORCID 0000-0001-5066-8306
Marie-Louise Kulas SøborgDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.
Agneta Henriette SnoerH. Lundbeck A/S, Valby, Denmark.
Rigmor Højland JensenDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.
Thomas Folkman HansenDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.ORCID 0000-0001-6703-7762
Anja Sofie PetersenDanish Headache Center, Department of Neurology Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.ORCID 0000-0002-0125-6038

Funding

The Capital Region of Denmarks Research Foundation A7315
6 · The paper itself

Abstract

objectiveInvestigate the immune system's role in cluster headache by analyzing cytokines in people with cluster headache and headache-free controls, and explore if certain cytokines could predict a specific phenotype.

methodsWe measured 45 cytokines in adult participants from the Danish Cluster Headache Biobank in a prospective case-control setup. People with cluster headache were diagnosed according to the International Classification of Headache Disorders third-edition. Controls were matched for age and sex.

resultsA total of 412 were analyzed deriving from 99 with chronic cluster headache, 108 with episodic cluster headache (ECH) in bout, 105 with ECH in remission, and 100 successfully matched controls. Compared with controls, 13 cytokines were altered for ECH in bout (p < 0.05), 3 in remission (p < 0.05), and 10 for chronic cluster headache (p < 0.05). Oncostatin m was significantly elevated in all 3 disease states compared with controls (p < 0.05). Overall, the investigated cytokines showed distinct patterns of alterations between chronic cluster headache and episodic cluster headache in bout and, interestingly, IL-1β was significantly associated with having chronic cluster headache rather than episodic in bout in a logistic regression model adjusting for potential confounders (p < 0.05).

interpretationFindings show that the immune system is altered in all 3 states of cluster headache compared with controls. Oncostatin m was elevated, constituting a promising target for future studies. The distinct alterations between episodic and chronic cluster headache are striking and urges further research of the immune system in cluster headache to better understand its potential role in prediction of disease activity and treatment response. ANN NEUROL 2025;98:4-18.

Indexed as

Cluster HeadacheCytokinesAdultBiomarkersCase-Control StudiesDenmarkFemaleHumansInflammationMaleMiddle AgedProspective StudiesBiomarkersCytokines

Identifiers

PMID39981939
PMCPMC12174737

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.